Form 4: Clorox Director Boosts Stake with Deferred Stock Units

Clorox Director Christopher J. Williams increased his beneficial ownership of the company's stock through the acquisition of deferred stock units via dividend reinvestment and director's fees.

Summary

• Christopher J. Williams, a Director of The Clorox Co. (CLX), acquired additional Deferred Stock Units (DSUs).
• On August 29, 2025, 199.8083 DSUs were acquired through dividend reinvestment as part of the Independent Directors' Deferred Compensation Plan.
• On September 30, 2025, an additional 212.8954 DSUs were received in lieu of quarterly director's fees.
• The DSUs will be settled 100% in Clorox common stock upon the reporting person's retirement or other termination of service as a Director.
• Following these transactions, Christopher J. Williams beneficially owns a total of 19,458.9483 Deferred Stock Units directly.
• The acquisition price for these DSUs was $0.0000, as they were received through compensation and dividend reinvestment.

Sentiment

Score: 7

Explanation: The acquisition of additional deferred stock units by a director, even if not a direct cash purchase, generally indicates continued confidence in the company's long-term prospects and aligns management incentives with shareholder interests.

Positives

• A Director increasing their beneficial ownership, even through deferred units, can signal confidence in the company's future performance.
• The use of Deferred Stock Units aligns the Director's long-term interests with those of shareholders, as settlement is in company stock upon service termination.

Negatives

• The acquisitions were not direct cash purchases, but rather through dividend reinvestment and in lieu of cash fees, meaning no new capital was invested by the director.

Future Outlook

The Deferred Stock Units will be settled 100% in Clorox common stock in connection with the reporting person's retirement or other termination of service as a Director.

Industry Context

This transaction is a routine insider filing reflecting a director's compensation structure and does not provide broader industry insights or competitive analysis.

Corporate Governance

Related Party Transactions

• Acquisition of Deferred Stock Units by Director Christopher J. Williams as part of his compensation, including dividend reinvestment and in lieu of quarterly director's fees, constitutes a related party transaction.

Stakeholder Impact

• Shareholders may view the director's increased equity stake as a positive signal of management's commitment and belief in the company's future.
• The compensation structure for directors, involving deferred stock units, aims to align their financial interests with the long-term performance for all shareholders.

Next Steps

• The Deferred Stock Units will be settled in Clorox stock upon the Director's retirement or termination of service.

Key Dates

Recommendation

This Form 4 filing reports routine insider transactions related to director compensation and dividend reinvestment. While the increase in beneficial ownership by a director is generally a positive signal of confidence, it does not involve a direct cash investment and is not significant enough on its own to warrant a change in investment recommendation. It serves as a data point supporting a 'hold' position, indicating stable insider alignment without providing new fundamental catalysts for a 'buy' or 'sell'.

Keywords

Clorox, CLX, Insider Transaction, Form 4, Director Compensation, Deferred Stock Units, Equity Compensation, Beneficial Ownership